changed Source changed

A new raw object was archived. Both versions are preserved. 4 line(s) added, 4 line(s) removed.

Evidence

Source	FDA — Press Announcements
Agency	FDA
URL	https://www.fda.gov/news-events/newsroom/press-announcements
Observed by	Civic Memory, directly, on 2026-08-29T00:26:35+00:00
Content type	text/html; charset=UTF-8
Current object	`20d0dc86089cd4a06f2a3b1b38608c42f88ce8eb82c35a0926fc9d4c11d5c6a2` download raw metadata
Previous object	`faa2c32050be018c542f8a961eefa683a0c8979a7ded0018ea89c0a8c7c869ef` download raw metadata

What changed derived

This diff is not evidence. It was produced by civic-memory.diff_engine 1.1.0 at 2026-08-29T00:26:35+00:00 by normalizing the two archived objects above. The objects are authoritative; this reading of them can be regenerated or deleted without loss. 4 line(s) added, 4 line(s) removed.

--- previous
+++ current
@@ -144,6 +144,10 @@
 
 August 2026
 
+August 28, 2026
+
+ - FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
+
 August 27, 2026
 
  - FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
@@ -179,10 +183,6 @@
 August 7, 2026
 
  - FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine
-
-August 6, 2026
-
- - FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
 
 Pagination